Local Ties In Suit Against Opioid Manufacturer Makes Case Personal For New Jersey Officials

The Johnson & Johnson subsidiary that New Jersey says minimized the risks of opioid addiction in its marketing messages is based in the state. “It is especially troubling that so much of the alleged misconduct took place right here in our own backyard,”said Gurbir Grewal, the New Jersey attorney general, at a news conference announcing the legal action. “New Jersey’s pharmaceutical industry is the envy of the world, with a long history of developing vital, lifesaving drugs. But we cannot turn a blind eye when a New Jersey company like Janssen violates our laws and threatens the lives of our residents.” Meanwhile, Naloxone can be a lifesaving drug, but not all pharmacies are on board with offering it. News on the epidemic comes out of Oregon, Kansas, New Hampshire and California, as well.

from Kaiser Health News https://ift.tt/2z930mi